Skip to main content
. 2019 Jul 30;44(2):214–217. doi: 10.5114/ceji.2019.87075

Fig. 2.

Fig. 2

Serum levels of IL-33 (pg/ml) before immunotherapy (ITA) and after the first course of immunotherapy (ITA-II)